Human T Cell Clones Reactive with Hepatitis B Virus (HBV) Surface Antigen from a HBV Vaccine Recipient

Overview

Journal Gastroenterol Jpn

Specialty Gastroenterology

Date 1987 Apr 1

PMID 2954874

Citations 1

Authors

A Nonomura

G Ohta

Affiliations

Soon will be listed here.

Abstract

Five T-cell clones reactive with HBsAg were obtained from peripheral blood lymphocytes of a HBV vaccine recipient by means of in vitro stimulation of lymphocytes for 5 days by HBsAg and subsequent re-culture of lymphocytes with HBsAg, feeder cells and T cell growth factor (TCGF) for 6 days, followed by the limiting dilution method. Clones, and subclones derived from one original clone showed a specific proliferative response to HBsAg in the presence of autologous feeder cells but not to unrelated antigens, such as influenza virus antigens, herpes simplex antigens, toxoplasma antigens, and PPD. All clones were found to have a surface marker of helper/inducer phenotype, Leu 1+, Leu 2a-, and Leu 3a+, detected by an indirect immunofluorescence method. These clones, however, did not show a substantial helper effect for in vitro anti-HBs production by autologous B cells. This suggests that the mechanism of the helper effect by specific T-cell clones is implicated, and functions of such clones other than specific helper effect on antibody-producing B cells must be considered.

Citing Articles

Production of lymphokines by HBsAg-reactive human T cell clones upon antigenic stimulation.

Nonomura A, Ohta G Gastroenterol Jpn. 1987; 22(4):453-8.

PMID: 3117613 DOI: 10.1007/BF02773813.

References

Lamb J, Woody J, Hartzman R, Eckels D . In vitro influenza virus-specific antibody production in man: antigen-specific and HLA-restricted induction of helper activity mediated by cloned human T lymphocytes. J Immunol. 1982; 129(4):1465-70. View

Roberts I, Bernard C, VYAS G, Mackay I . T-cell dependence of immune response to hepatitis B antigen in mice. Nature. 1975; 254(5501):606-7. DOI: 10.1038/254606a0. View

DUDLEY F, Fox R, Sherlock S . Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet. 1972; 1(7753):723-6. DOI: 10.1016/s0140-6736(72)90234-6. View

Nonomura A, Ohta G, Kobayashi K, Kato Y . Activities of lymphocytes mediating antibody-dependent cell-mediated cytotoxicity in patients with chronic active hepatitis. Tohoku J Exp Med. 1981; 135(1):63-77. DOI: 10.1620/tjem.135.63. View

Muraguchi A, Butler J, Kehrl J, Fauci A . Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor. J Exp Med. 1983; 157(2):530-46. PMC: 2186942. DOI: 10.1084/jem.157.2.530. View

Mittler R, Rao P, Olini G, Westberg E, Newman W, Hoffmann M . Activated human B cells display a functional IL 2 receptor. J Immunol. 1985; 134(4):2393-9. View

Fathman C, Hengartner H . Clones of alloreactive T cells. Nature. 1978; 272(5654):617-8. DOI: 10.1038/272617a0. View

Chang T, Celis E, Miller R, Zurawski Jr V, Kung P . In vitro response to HBsAg of peripheral blood lymphocytes from recipients of hepatitis B vaccine. Hepatology. 1984; 4(5):824-9. DOI: 10.1002/hep.1840040504. View

Malissen B, Kristensen T, Goridis C, Madsen M, Mawas C . Clones of human cytotoxic T lymphocytes derived from an allosensitized individual: HLA specificity and cell surface markers. Scand J Immunol. 1981; 14(3):213-24. DOI: 10.1111/j.1365-3083.1981.tb00558.x. View

10.

Kimoto M, Fathman C . Antigen-reactive T cell clones. I. Transcomplementing hybrid I-A-region gene products function effectively in antigen presentation. J Exp Med. 1980; 152(4):759-70. PMC: 2185955. DOI: 10.1084/jem.152.4.759. View

11.

Eddleston A, Williams R . Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet. 1974; 2(7896):1543-5. DOI: 10.1016/s0140-6736(74)90287-6. View

12.

Boyd A, Fisher D, Fox D, Schlossman S, Nadler L . Structural and functional characterization of IL 2 receptors on activated human B cells. J Immunol. 1985; 134(4):2387-92. View

13.

Nonomura A, Tanino M, Kurumaya H, Ohta G, Kato Y, Kobayashi K . Disordered immunoregulatory functions in patients with chronic active hepatitis. Clin Exp Immunol. 1982; 47(3):595-605. PMC: 1536421. View

14.

Thomas H, Brown D, Routhier G, Janossy G, Kung P, Goldstein G . Inducer and suppressor T-cells in hepatitis B virus-induced liver disease. Hepatology. 1982; 2(2):202-4. DOI: 10.1002/hep.1840020203. View

15.

Celis E, Chang T . Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen. Science. 1984; 224(4646):297-9. DOI: 10.1126/science.6231724. View

16.

Nonomura A, Ohmori K, Ohta G, Kato Y, Kobayashi K, Nishimura I . T cell-mediated cytotoxicity against HBsAg-coated Chang cells in patients with chronic hepatitis: evidence for cytotoxicity mediated by delayed hypersensitivity T cell reaction. Tohoku J Exp Med. 1982; 138(2):139-50. DOI: 10.1620/tjem.138.139. View

17.

Celis E, Kung P, Chang T . Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis. J Immunol. 1984; 132(3):1511-6. View

18.

Morgan D, Ruscetti F, Gallo R . Selective in vitro growth of T lymphocytes from normal human bone marrows. Science. 1976; 193(4257):1007-8. DOI: 10.1126/science.181845. View

19.

Fischer A, Nash S, Beverley P, Feldmann M . An influenza virus matrix protein-specific human T cell line with helper activity for in vitro anti-hemagglutinin antibody production. Eur J Immunol. 1982; 12(10):844-9. DOI: 10.1002/eji.1830121009. View